Posts Tagged: Regents of the University of California v. Eli Lilly


The Evolution of Antibody Patents

As the pharmaceutical industry continues to shift toward biologic-based drugs, including monoclonal antibodies, protecting the underlying technology has been and continues to be a priority for companies. …
By Karen Carroll & Sharad Bijanki
12 months ago 0